Analgesics in Belgium

Date: September 23, 2016
Pages: 37
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AA805F233A7EN
Leaflet:

Download PDF Leaflet

In spite of the favourable weather for pathologies during spring 2016, sales of adult analgesics continued to wane in volume terms in 2016, in continuation of the previous year. This stemmed from the mild winter in 2016: in terms of epidemiology, there was almost no peak of flu from January to March, by contrast with the similar period in 2015. Belgians usually over-consume analgesics such as ibuprofen and acetaminophen, in particular at the first sign of cold or flu symptoms. In addition, the o...

Euromonitor International's Analgesics in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Analgesics by Category: Value 2011-2016
  Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
  Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
  Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
  Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Janssen-cilag NV in Consumer Health (belgium)
Strategic Direction
Key Facts
  Summary 1 Janssen-Cilag NV: Key Facts
  Summary 2 Janssen-Cilag NV: Operational Indicators
Competitive Positioning
  Summary 3 Janssen-Cilag NV: Competitive Position 2016
Merck Consumer Healthcare Belgium NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
  Summary 4 Merck Consumer Healthcare Belgium NV SA: Key Facts
  Summary 5 Merck Consumer Healthcare Belgium NV SA: Operational Indicators
Competitive Positioning
  Summary 6 Merck Consumer Healthcare Belgium NV SA: Competitive Position 2016
Omega Pharma Belgium NV in Consumer Health (belgium)
Strategic Direction
Key Facts
  Summary 7 Omega Pharma Belgium NV: Key Facts
  Summary 8 Omega Pharma Belgium NV: Operational Indicators
Competitive Positioning
  Summary 9 Omega Pharma Belgium NV: Competitive Position 2016
Executive Summary
Detrimental Impact of the Weather and the Economy
Local Distrust and Constraints Continue To Hamper Sales
Multinationals Lead, But Do Not Perform As Well As Domestic Players
Beginning of Change in Distribution, Which Is Still Controlled by Chemists/pharmacies
Possible Ongoing Loss of Momentum for Consumer Health
Key Trends and Developments
the Belgian Economy and Consumer Health Run Into the Sand From 2015
Restrictive Legislation and Scandals Create Doubt, But Favour Alternatives
Possible Changes in Distribution Could Favour Branding and Change the Competitive Landscape
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
  Table 9 Life Expectancy at Birth 2011-2016
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2011-2016
  Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
  Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
  Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
  Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 10 OTC: Switches 2014-2016
Definitions
Sources
  Summary 11 Research Sources












Skip to top


OTC Pharmaceuticals in Belgium US$ 350.00 Sep, 2014 · 38 pages
Adult Mouth Care in Belgium US$ 990.00 Sep, 2016 · 26 pages
Calming and Sleeping in Belgium US$ 990.00 Jun, 2015 · 24 pages

Ask Your Question

Analgesics in Belgium
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: